EligibleTrials

Clinical trials recruiting for Percutaneous Coronary Intervention

6
Recruiting trials
36
US states with sites
4
Countries
0%
Accept healthy volunteers

Phase breakdown

Phase 2 1Phase 3 1Phase 4 1Not applicable 4

Drugs and treatments being studied

InterventionTrials
Amlodipine + Azilsartan1
Aspirin + Clopidogrel1
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL1
Losartan + Hydrochlorothiazide1
Rivaroxaban + Clopidogre1

Where trials are recruiting (top US states)

StateRecruiting trials
Pennsylvania2
Texas2
Virginia2
Alabama1
Arizona1
Arkansas1
California1
Colorado1
Connecticut1
Florida1
Georgia1
Illinois1

Top cities

Richmond, Virginia 2Albany, New York 1Albuquerque, New Mexico 1Alexander City, Alabama 1Amarillo, Texas 1Anderson, South Carolina 1Asheville, North Carolina 1Aurora, Colorado 1Austin, Texas 1Avondale, Arizona 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Percutaneous Coronary Intervention often also study these conditions. Each links to its own recruiting-trial list.

Heart failure 1021Myocardial Infarction 23Hypertension 1201High cholesterol 103End-stage renal disease 49Dialysis 8Coronary artery disease 45Chronic kidney disease 588Chronic Heart Failure 32Cerebrovascular Accident 3

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Percutaneous Coronary Intervention trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.